Human Genome Epidemiology Literature Finder
Records 1 - 25 (of 25 Records) |
Query Trace: Carcinoma and TSC2[original query] |
---|
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1. PloS one 2011 6 (4): e18583. Sjödahl Gottfrid, Lauss Martin, Gudjonsson Sigurdur, Liedberg Fredrik, Halldén Christer, Chebil Gunilla, Månsson Wiking, Höglund Mattias, Lindgren Dav |
Do patients with tuberous sclerosis complex have an increased risk for malignancies? American journal of medical genetics. Part A 2016 Apr . Peron Angela, Vignoli Aglaia, La Briola Francesca, Volpi Angela, Montanari Emanuele, Morenghi Emanuela, Ghelma Filippo, Bulfamante Gaetano, Cefalo Graziella, Canevini Maria Pao |
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Kwiatkowski David J, Choueiri Toni K, Fay Andre P, Rini Brian I, Thorner Aaron R, De Velasco Guillermo, Tyburczy Magdalena, Hamieh Lana, Albiges Laurence, Agarwal Neeraj, Ho Thai H, Song Jiaxi, Pignon Jean-Christophe, Barrios Pablo M, Michaelson M Dror, Van Allen Eliezer M, Krajewski Katherine M, Porta Camillo, Pal Sumanta Kumar, Bellmunt Joaquim, McDermott David F, Heng Daniel Y C, Gray Kathryn P, Signoretti Sabi |
Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. JAMA oncology 2016 May 2 (5): 616-624. Parsons D Williams, Roy Angshumoy, Yang Yaping, Wang Tao, Scollon Sarah, Bergstrom Katie, Kerstein Robin A, Gutierrez Stephanie, Petersen Andrea K, Bavle Abhishek, Lin Frank Y, López-Terrada Dolores H, Monzon Federico A, Hicks M John, Eldin Karen W, Quintanilla Norma M, Adesina Adekunle M, Mohila Carrie A, Whitehead William, Jea Andrew, Vasudevan Sanjeev A, Nuchtern Jed G, Ramamurthy Uma, McGuire Amy L, Hilsenbeck Susan G, Reid Jeffrey G, Muzny Donna M, Wheeler David A, Berg Stacey L, Chintagumpala Murali M, Eng Christine M, Gibbs Richard A, Plon Sharon |
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 2018 Sep 119 (6): 707-712. Bellmunt Joaquim, Lalani Aly-Khan A, Jacobus Sussana, Wankowicz Stephanie A, Polacek Laura, Takeda David Y, Harshman Lauren C, Wagle Nikhil, Moreno Irene, Lundgren Kevin, Bossé Dominick, Van Allen Eliezer M, Choueiri Toni K, Rosenberg Jonathan |
TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery. Thoracic cancer 2019 Feb 10 (2): 335-340. Lee Yong Hoon, Do Sook Kyung, Lee Shin Yup, Kang Hyo-Gyoung, Choi Jin Eun, Hong Mi Jeong, Lee Jang Hyuck, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Lee Won Kee, Seok Yangki, Cho Sukki, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Jheon Sanghoon, Park Jae Yo |
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. The oncologist 2018 10 24 (6): 791-797. Kang Hyunseok, Pettinga Dean, Schubert Adrian D, Ladenson Paul W, Ball Douglas W, Chung Jon H, Schrock Alexa B, Madison Russell, Frampton Garrett M, Stephens Phil J, Ross Jeffrey S, Miller Vincent A, Ali Siraj |
PTEN Expression, Not Mutation Status in TSC1, TSC2, or mTOR, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 10 25 (2): 506-514. Voss Martin H, Chen David, Reising Albert, Marker Mahtab, Shi Jiayuan, Xu Jianning, Ostrovnaya Irina, Seshan Venkatraman E, Redzematovic Almedina, Chen Ying-Bei, Patel Parul, Han Xia, Hsieh James J, Hakimi A Ari, Motzer Robert |
Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes. The American journal of surgical pathology 2020 7 44 (11): 1479-1486. Shah Abhishek, Lal Priti, Toorens Erik, Palmer Matthew B, Schwartz Lauren, Vergara Norge, Guzzo Thomas, Nayak Anup |
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene 2020 Oct . von Felden Johann, Craig Amanda J, Garcia-Lezana Teresa, Labgaa Ismail, Haber Philipp K, D'Avola Delia, Asgharpour Amon, Dieterich Douglas, Bonaccorso Antoinette, Torres-Martin Miguel, Sia Daniela, Sung Max W, Tabrizian Parissa, Schwartz Myron, Llovet Josep M, Villanueva Augus |
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet journal of rare diseases 2021 Jul 16 (1): 301. Sauter Matthias, Belousova Elena, Benedik Mirjana P, Carter Tom, Cottin Vincent, Curatolo Paolo, Dahlin Maria, D'Amato Lisa, d'Augères Guillaume B, de Vries Petrus J, Ferreira José C, Feucht Martha, Fladrowski Carla, Hertzberg Christoph, Jozwiak Sergiusz, Lawson John A, Macaya Alfons, Marques Ruben, Nabbout Rima, O'Callaghan Finbar, Qin Jiong, Sander Valentin, Shah Seema, Takahashi Yukitoshi, Touraine Renaud, Youroukos Sotiris, Zonnenberg Bernard, Jansen Anna, Kingswood J Chris, |
An integrative microenvironment approach for laryngeal carcinoma: the role of immune/methylation/autophagy signatures on disease clinical prognosis and single-cell genotypes. Journal of Cancer 2021 6 12 (14): 4148-4171. Kang Xueran, Chen Yisheng, Yi Bin, Yan Xiaojun, Jiang Chenyan, Chen Bin, Lu Lixing, Sun Yuxing, Shi Runj |
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 3 27 (14): 3845-3853. Adib Elio, Klonowska Katarzyna, Giannikou Krinio, Do Khanh T, Pruitt-Thompson Solida, Bhushan Ketki, Milstein Matthew I, Hedglin Jennifer, Kargus Katherine E, Sholl Lynette M, Tsuji Junko, Hyman David M, Sisk Anne, Shapiro Geoffrey I, Vargas Hebert A, Harding James J, Voss Martin H, Iyer Gopa, Kwiatkowski David |
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy. Pharmacogenomics and personalized medicine 2021 2 14 269-278. Song Kangjian, He Fu, Xin Yang, Guan Ge, Huo Junyu, Zhu Qingwei, Fan Ning, Guo Yuan, Zang Yunjin, Wu Liq |
Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma. Frontiers in oncology 2021 12 11 737547. Kong Wen, Yang Tongtong, Wen Xiaodong, Mu Zhongyi, Zhao Cheng, Han Sujun, Tian Jing, Zhang Xinhao, Zhou Tao, Zhang Yanrui, Lou Feng, Cao Shanbo, Wang Huina, Zhang J |
Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations. Genetics and molecular biology 2022 5 45 (2): e20200387. Wang Wenda, Zhao Yang, Wang Xu, Wang Zhan, Cai Yi, Li Hanzhong, Zhang Yus |
Rap_GAP Domain of TSC2 Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular Carcinoma. DNA and cell biology 2022 2 41 (2): 215-224. Cui Mengying, Jiang Weibo, Sheng Jiyao, Wu Jiacheng, Zhang Xuew |
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma. JCO precision oncology 2023 9 7 e2300272. Darren Cowzer, Jessica B White, Joanne F Chou, Pin-Jung Chen, Tae-Hyung Kim, Danny N Khalil, Imane H El Dika, Katrina Columna, Amin Yaqubie, Joseph S Light, Jinru Shia, Hooman Yarmohammadi, Joseph Patrick Erinjeri, Alice C Wei, William Jarnagin, Richard K G Do, David B Solit, Marinela Capanu, Ronak H Shah, Michael F Berger, Ghassan K Abou-Alfa, James J Hardi |
Spectrum of germline and somatic mitochondrial DNA variants in Tuberous Sclerosis Complex. Frontiers in genetics 2023 2 13 917993. Giannikou Krinio, Martin Katie R, Abdel-Azim Ahmad G, Pamir Kaila J, Hougard Thomas R, Bagwe Shefali, Tang Yan, MacKeigan Jeffrey P, Kwiatkowski David J, Henske Elizabeth P, Lam Hilaire |
Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation. Frontiers in oncology 2024 4 14 1357980. Mariko Peterson, David L Kolin, Panagiotis A Konstantinopoul |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: